In future, Stefan H.E. Kaufmann's Emeritus Group will mainly focus on bioinformatics analyses in systems immunology. In particular, bioinformatics will be used to predict the safety and protective effects of vaccines and the risk of disease in infected persons. This topic covers the terms:
- Systems biology of tuberculosis
- Systems vaccinology
- Rational design of a vaccine against tuberculosis
- Biomarkers of susceptibility/resistance in tuberculosis
Press releases and research news
The Münster University Society honors the Max Planck scientist for his research achievements in the field of infection biology. The award is endowed with 20,000 euros and was ceremoniously awarded on November 8. (in German)
VPM1002, developed by Emeritus Director Stefan H.E. Kaufmann and his team, has also fewer side effects compared to BCG, the only vaccine available to date o prevent tuberculosis .
Together with his team, Stefan H. E. Kaufmann has advanced the development of a new vaccine against tuberculosis, which could also serve as an interim solution for Covid-19. The infection biologist will continue his research with an emeritus group in Göttingen.